Chronic News and Research

RSS

Hope for back pain: Minimally invasive facet arthrodesis and spinal cord stimulation

Results from the first prospective study of minimally invasive facet arthrodesis and long-term data on spinal cord stimulation demonstrate the viability of these options to achieve pain relief in patients with various back pain conditions. The studies were presented today at the American Academy of Pain Medicine's 26th Annual Meeting in San Antonio, TX.

5 Feb 2010

Findings reveal racial disparities in pain treatment outcomes

Findings from a retrospective analysis of a three-week treatment program for chronic pain revealed African Americans experienced worse outcomes compared to a matched group of Caucasians.

5 Feb 2010

Physmark introduces HealthKeys for preventive care programs

Physmark has announced HealthKeys, a software system and service based on the company's patent-pending cost model that measures the effectiveness and cost savings of preventive care programs.

5 Feb 2010

TGen completes strategic alliance and affiliation agreement with VARI

The Translational Genomics Research Institute (TGen) today announced the completion of a strategic alliance and affiliation agreement with the Van Andel Research Institute (VARI) that will maximize the research capabilities of both non-profit institutes.

5 Feb 2010

CCHP implements TriZetto systems to improve its network and health management programs

The TriZetto Group, Inc. today announced that Chinese Community Health Plan (CCHP) has successfully implemented several TriZetto systems, including the Facets®, NetworX Pricer® and Clinical CareAdvance® applications.

5 Feb 2010

NHLBI awarded four contracts to test new devices to help children with congenital heart defects

The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has awarded four contracts totaling $23.6 million to begin preclinical testing of devices to help children born with congenital heart defects or those who develop heart failure.

5 Feb 2010

Anthem Blue Cross introduces DailyMed Pharmacy program for Medi-Cal members

Imagine having to face the daily struggle of taking six or more different medications a day to manage a chronic health condition; add to this the worry of missing or taking a dose incorrectly. For Anthem Blue Cross (Anthem) Medi-Cal members, that daily struggle will now be simplified to help increase medication adherence and reduce medication errors.

5 Feb 2010

Aradigm's first U.S. sale of SUMAVEL DosePro needle-free delivery system triggers $4M milestone payment

Aradigm Corporation announced today that it received the $4 million milestone payment from Zogenix, Inc. (“Zogenix”) based upon the first commercial sale in the U.S. of SUMAVEL* DosePro* (sumatriptan injection) needle-free delivery system. The Company will receive quarterly royalty payments on all SUMAVEL DosePro sales. In 2006, the Company sold all assets related to the Intraject* needle-free injector technology (now rebranded as DosePro) to Zogenix in exchange for milestone and royalty payments.

5 Feb 2010

Study finds high levels of depression among children abused in the first five years of their lives

Although children can be depressed for many reasons, new evidence suggests that there are physiological differences among depressed children based on their experiences of abuse before age 5. Early abuse may be especially damaging due to the very young age at which it occurs.

5 Feb 2010

Research could help in developing more effective treatments for wound infections

Bacteria that infect chronic wounds can be deadly to maggot 'biosurgeons' used to treat the lesions, show researchers writing in the journal Microbiology. The findings could lead to more effective treatment of wounds and the development of novel antibiotics.

5 Feb 2010

Online programs may help Americans incorporate more fruits and vegetables in their diet

Online programs that provide information and tips about fruits and vegetables may be the key to getting more Americans to eat healthier, say researchers at Henry Ford Hospital.

5 Feb 2010

Majority of rural hospital stays are covered by Medicare

Medicare patients accounted for almost half of all stays (45 percent) at rural hospitals in 2007, while the percentage of Medicare beneficiaries who were admitted to urban hospitals was considerably lower (35 percent) , according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

5 Feb 2010

Global cancer rates could be reduced by 40% with prevention strategies, report says

"Forty percent of the 12 million people diagnosed with cancer worldwide each year could avert the killer disease by protecting themselves against infections and changing their lifestyles, experts said on Tuesday," Reuters reports.

4 Feb 2010

Alkermes develops proprietary LinkeRx technology platform to create injectable antipsychotics

Alkermes, Inc. today announced that it has developed a novel, proprietary LinkeRx™ technology platform to enable the creation of injectable extended-release versions of antipsychotics and other central nervous system (CNS) therapies.

4 Feb 2010

BioCryst Pharmaceuticals announces fourth-quarter and full-year 2009 financial results

BioCryst Pharmaceuticals, Inc. today announced financial results for the fourth quarter and year ended December 31, 2009.

4 Feb 2010

February issue of Chest releases latest medical news

Inhaled corticosteroids (ICS) are widely used for the treatment of chronic obstructive pulmonary disease (COPD). However, new research suggests that ICS may only provide a modest benefit in reducing exacerbations in patients with COPD.

4 Feb 2010

Health Canada accepts AbstralTM New Drug Submission for review

Orexo AB today confirms that its partner, ProStrakan Group plc has announced that the New Drug Submission made by their Canadian partner, Paladin Labs Inc., for AbstralTM has been accepted for review by Health Canada, the Canadian Government Department with responsibility for public health.

4 Feb 2010

Results from three phase two studies show the effectiveness of Tanezumab

Tanezumab, a humanized monoclonal antibody that targets nerve-growth factor, reduced pain in three common pain conditions, according to the results from three phase two studies presented today in a single poster at the American Academy of Pain Medicine's 26th Annual Meeting.

4 Feb 2010

Closing funding gap for federal viral hepatitis education, screening and surveillance programs stops liver cancer

With most liver cancer caused by undetected or untreated hepatitis B or C viral infection, the 22,000 new cases of liver cancer that are diagnosed each year could be dramatically reduced if Congress took decisive action to close the funding gap for federal viral hepatitis education, screening, and surveillance programs, the National Viral Hepatitis Roundtable (NVHR) said today.

4 Feb 2010

New program to help the U.S. health care sector switch to cleaner, renewable energy sources

In recent months, three U.S. hospitals signed energy contracts that will save over $1.7 million in energy costs, provide them with up to 10 percent clean energy. The green energy will avoid 11,829 metric tons of CO2 being released to our atmosphere, which is equivalent to taking 2,052 cars off the road or not burning 56 railcars' worth of coal.

4 Feb 2010

Chronic News and Research

Hope for back pain: Minimally invasive facet arthrodesis and spinal cord stimulation

Findings reveal racial disparities in pain treatment outcomes

Physmark introduces HealthKeys for preventive care programs

TGen completes strategic alliance and affiliation agreement with VARI

CCHP implements TriZetto systems to improve its network and health management programs

NHLBI awarded four contracts to test new devices to help children with congenital heart defects

Anthem Blue Cross introduces DailyMed Pharmacy program for Medi-Cal members

Aradigm's first U.S. sale of SUMAVEL DosePro needle-free delivery system triggers $4M milestone payment

Study finds high levels of depression among children abused in the first five years of their lives

Research could help in developing more effective treatments for wound infections

Online programs may help Americans incorporate more fruits and vegetables in their diet

Majority of rural hospital stays are covered by Medicare

Global cancer rates could be reduced by 40% with prevention strategies, report says

Alkermes develops proprietary LinkeRx technology platform to create injectable antipsychotics

BioCryst Pharmaceuticals announces fourth-quarter and full-year 2009 financial results

February issue of Chest releases latest medical news

Health Canada accepts AbstralTM New Drug Submission for review

Results from three phase two studies show the effectiveness of Tanezumab

Closing funding gap for federal viral hepatitis education, screening and surveillance programs stops liver cancer

New program to help the U.S. health care sector switch to cleaner, renewable energy sources

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News